Loading...
Immunization for meningococcal serogroup B: What does the practitioner need to know?
Most invasive meningococcal disease in Canada is now caused by serogroup B organisms. A vaccine directed against this serogroup (4CMenB) is newly licensed in Canada. A decision will need to be made by all provinces and territories regarding whether a routine infant immunization program is warranted....
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Pulsus Group Inc
2014
|
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3941677/ https://ncbi.nlm.nih.gov/pubmed/24596484 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|